北美血尿治疗市场预测至 2028 年 - COVID-19 影响和治疗（药物、疗法等）、适应症（尿路感染、肾结石、尿道炎、血癌、膀胱结石、前列腺癌、膀胱炎、创伤）的区域分析、剧烈运动、多囊肾、子宫内膜异位症和月经）、类型（肉眼血尿、镜下血尿、特发性血尿和慢跑者血尿）、最终用户（医院、诊所和门诊手术中心等）

市场介绍

血尿是一种在尿液中发现血液的疾病。一般来说，尿液中不含红细胞，因此可能会导致严重的问题，还可能导致肾结石、尿路感染和其他遗传性疾病。

此外，血尿的患病率很高预计相关迹象将在预测期内促进市场增长。然而，相关适应症的未确诊病例限制了北美血尿治疗市场的增长。

大流行为肾病市场的参与者提供了重要的增长机会。这种可能性是由于受冠状病毒影响的患者数量不断增加。例如，根据美国肾脏病学会的报告，为了应对 COVID-19，入住重症监护病房 (ICU) 的一半冠状病毒阳性患者出现肾衰竭，需要某种形式的透析。报告指出，ICU 中约有 10% 至 50% 的患者出现肾衰竭，近 17% 的患者需要紧急透析，46% 的患者出现某种形式的急性肾损伤 (AKI)。在整个北美地区，美国登记的受冠状病毒影响的患者人数最多。因此，越来越多的患者面临更高的急性肾损伤（AKI）风险，包括肾小管损伤伴感染性休克、微炎症、凝血增加以及可能的肾脏直接感染。因此，预计将增加对肾脏疾病管理产品的需求，从而导致未来市场的增长。

市场概况和动态

北美血尿治疗市场预计将从2021年的3.516亿美元增至2028年的4.197亿美元；预计 2021 年至 2028 年复合年增长率为 2.6%。医疗设备和诊断程序的技术发展带来了治疗血尿相关适应症的多种选择，例如肾结石、膀胱结石和尿路感染。先进治疗技术的使用有望改善患者护理。例如，近年来，机器人技术在治疗尿石症手术中的应用越来越受欢迎。目前，Intuitive Surgical Inc. 的 Vinci 手术系统广泛用于治疗尿石症的手术。同样，各国对肾结石的腔内泌尿外科干预措施的采用也显着增加。预计相关适应症的进步可能会在预测期内支持北美血尿治疗市场。

关键细分市场

从类型来看，肉眼血尿细分市场在2020年北美血尿治疗市场中占据最大份额。从治疗来看，药物细分市场在2020年北美血尿治疗市场中占据最大份额。从适应症来看，尿路感染细分市场在2020年北美血尿治疗市场中占据最大份额。从最终用户来看，医院细分市场占据2020年北美血尿治疗市场最大份额。

主要来源和上市公司

准备本北美血尿治疗市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司包括阿斯利康、百时美施贵宝公司、F. HOFFMANN-LA ROCHE LTD.、葛兰素史克公司、杨森制药、默沙东制药公司和默沙东制药公司。 Co., Inc.、Novartis AG、Pfizer Inc.、Sun Pharmaceutical Industries Ltd 和 Boehringer Ingelheim International GmbH。

购买报告的理由

了解北美血尿治疗市场格局并确定细分市场可能保证丰厚的回报
了解不断变化的市场格局并在竞争中保持领先
通过识别最有可能销售的细分市场，有效规划北美血尿治疗市场的并购和合作交易
通过敏锐而全面的分析，做出明智的业务决策各个细分市场的市场表现
获得2021年-2028年基于各个细分市场的北美血尿治疗市场的市场收入预测

北美血尿治疗市场细分

作者治疗

药物

疗法
其他

按适应症 span>

尿路感染
肾结石

尿道炎
血癌
膀胱结石
前列腺癌
膀胱炎
外伤
剧烈运动
多囊肾
子宫内膜异位症
月经
子宫内膜异位症
月经
span>

按类型

肉眼血尿
显微镜下血尿
特发性血尿
慢跑者血尿

最终用户

医院
诊所
门诊手术中心 (ASC)
其他

按国家/地区

北美
美国
加拿大
墨西哥

提及的公司

TABLE OF CONTENTS
1.           Introduction
1.1         Scope of the Study
1.2         The Insight Partners Research Report Guidance
1.3         Market Segmentation
1.3.1        North America Hematuria Treatment Market – By Treatment
1.3.2        North America Hematuria Treatment Market – By Indication
1.3.3        North America Hematuria Treatment Market – By Type
1.3.4        North America Hematuria Treatment Market – By End User
1.3.5        North America Hematuria Treatment Market – By Country
2.           North America Hematuria Treatment Market – Key Takeaways
3.        Research Methodology
3.1         Coverage
3.2         Secondary Research
3.3         Primary Research
4.           Hematuria Treatment Market – Market Landscape
4.1         Overview
4.2         PEST Analysis
4.2.1        North America – PEST Analysis
4.3         Experts Opinion
5.           Hematuria Treatment Market – Key Market Dynamics
5.1         Market Drivers
5.1.1        High Prevalence of Hematuria-Associated Indications
5.1.2        Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2         Market Restraints
5.2.1        Undiagnosed Cases of Associated Indications
5.3         Market Opportunities
5.3.1        Increasing Opportunities for Related Treatments
5.4         Future Trends
5.4.1        Rise in Preference for Advanced Therapies
5.5         Impact Analysis
6.           Hematuria Treatment Market – North America Analysis
6.1         North America Hematuria Treatment Market Revenue Forecast and Analysis
7.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1         Overview
7.2         North America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3         Drugs
7.3.1        Overview
7.3.2        Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4         Therapies
7.4.1        Overview
7.4.2        Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5         Others
7.5.1        Overview
7.5.2        Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1         Overview
8.2         North America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3         Kidney Stones
8.3.1        Overview
8.3.2        Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4         Urinary Tract Infections (UTI)
8.4.1        Overview
8.4.2        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5         Urethritis
8.5.1        Overview
8.5.2        Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6         Blood Cancer
8.6.1        Overview
8.6.2        Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7         Bladder Stones
8.7.1        Overview
8.7.2        Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8         Prostate Cancer
8.8.1        Overview
8.8.2        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9         Cystitis
8.9.1        Overview
8.9.2        Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10      Trauma
8.10.1     Overview
8.10.2     Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11      Vigorous Exercise
8.11.1     Overview
8.11.2     Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12      Polycystic Kidney Disease
8.12.1     Overview
8.12.2     Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13      Endometriosis
8.13.1     Overview
8.13.2     Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14      Menstruation
8.14.1     Overview
8.14.2     Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9.           Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1         Overview
9.2         North America Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3         Macroscopic Hematuria
9.3.1        Overview
9.3.2        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4         Microscopic Hematuria
9.4.1        Overview
9.4.2        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5         Idiopathic Hematuria
9.5.1        Overview
9.5.2        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6         Jogger’s Hematuria
9.6.1        Overview
9.6.2        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10.        Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1      Overview
10.2      North America Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3      Hospitals
10.3.1     Overview
10.3.2     Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4      Clinics
10.4.1     Overview
10.4.2     Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5      Ambulatory Surgical Centers (ASC’s)
10.5.1     Overview
10.5.2     Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6      Others
10.6.1     Overview
10.6.2     Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11.        North America Hematuria Treatment Market – Geographic Analysis
11.1      North America: Hematuria Treatment Market
11.1.1     Overview
11.1.2     North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
11.1.2.1       US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.1       US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.2       US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.3       US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.4       US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.2.1.5       US: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.2       Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.1       Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.2       Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.3       Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.4       Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.2.2.5       Canada: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
11.1.2.3       Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.1       Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.2       Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.3       Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.4       Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
11.1.2.3.5       Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
12.        Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1      North America: Impact Assessment of COVID-19 Pandemic
13.        Hematuria Treatment Market–Industry Landscape
13.1      Overview
13.2      Growth Strategies Done by the Companies in the Market, (%)
13.3      Organic Developments
13.3.1     Overview
13.4      Inorganic Developments
13.4.1     Overview
14.        Company Profiles
14.1      AstraZeneca
14.1.1     Key Facts
14.1.2     Business Description
14.1.3     Products and Services
14.1.4     Financial Overview
14.1.5     SWOT Analysis
14.1.6     Key Developments
14.2      Bristol-Myers Squibb Company
14.2.1     Key Facts
14.2.2     Business Description
14.2.3     Products and Services
14.2.4     Financial Overview
14.2.5     SWOT Analysis
14.2.6     Key Developments
14.3      F. HOFFMANN-LA ROCHE LTD.
14.3.1     Key Facts
14.3.2     Business Description
14.3.3     Products and Services
14.3.4     Financial Overview
14.3.5     SWOT Analysis
14.3.6     Key Developments
14.4      GlaxoSmithKline Plc
14.4.1     Key Facts
14.4.2     Business Description
14.4.3     Products and Services
14.4.4     Financial Overview
14.4.5     SWOT Analysis
14.4.6     Key Developments
14.5      Janssen Pharmaceuticals
14.5.1     Key Facts
14.5.2     Business Description
14.5.3     Products and Services
14.5.4     Financial Overview
14.5.5     SWOT Analysis
14.5.6     Key Developments
14.6      Merck & Co., Inc.
14.6.1     Key Facts
14.6.2     Business Description
14.6.3     Products and Services
14.6.4     Financial Overview
14.6.5     SWOT Analysis
14.6.6     Key Developments
14.7      Novartis AG
14.7.1     Key Facts
14.7.2     Business Description
14.7.3     Products and Services
14.7.4     Financial Overview
14.7.5     SWOT Analysis
14.7.6     Key Developments
14.8      Pfizer Inc.
14.8.1     Key Facts
14.8.2     Business Description
14.8.3     Products and Services
14.8.4     Financial Overview
14.8.5     SWOT Analysis
14.8.6     Key Developments
14.9      Sun Pharmaceutical Industries Ltd
14.9.1     Key Facts
14.9.2     Business Description
14.9.3     Products and Services
14.9.4     Financial Overview
14.9.5     SWOT Analysis
14.9.6     Key Developments
14.10   Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15.        Appendix
15.1      About The Insight Partners
15.2      Glossary of Terms

LIST OF TABLES
Table 1.             US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 2.             US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 3.             US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 4.             US: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 5.             Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6.             Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 7.             Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8.             Canada: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)
Table 9.             Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 10.          Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 11.          Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 12.          Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13.          Organic Developments Done by Companies
Table 14.          Inorganic Developments Done by Companies
Table 15.          Glossary of Terms, Hematuria Treatment Market

LIST OF FIGURES
Figure 1.           Hematuria Treatment Market Segmentation
Figure 2.           North America Hematuria Treatment Market Overview
Figure 3.           Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4.           US to Show Significant Growth During Forecast Period
Figure 5.           North America Hematuria Treatment Market, Industry Landscape
Figure 6.           North America PEST Analysis
Figure 7.           Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8.           North America Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9.           North America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10.        Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11.        Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13.        North America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14.        Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15.        Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16.        Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17.        Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18.        Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19.        Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20.        Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21.        Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22.        Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23.        Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24.        Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25.        Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26.        North America Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27.        Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28.        Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29.        Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30.        Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31.        North America Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32.        Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33.        Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34.        Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35.        Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36.        North America: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)
Figure 37.        North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
Figure 38.        US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 39.        Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 40.        Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 41.        Impact Of COVID-19 Pandemic in North America Country Markets
Figure 42.        Growth Strategies Done by the Companies in the Market, (%)

AstraZeneca
Bristol-Myers Squibb Company
F. HOFFMANN-LA ROCHE LTD.
GlaxoSmithKline plc.
Janssen Pharmaceuticals
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd
Boehringer Ingelheim International GmbH

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America hematuria treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a.. May 2022

North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele.. May 2022

North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh.. May 2022

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.